Hanmi Pharm. Co., Ltd.

₩467,000As of Sun 8 Nov 2026, 12:00 UTC
KRX:128940Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 4.90%
Div yield 0.43%
ROE 16.36%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.60
PE TTM 27.31
TSR TTM 10.28%
Mkt cap ₩5.926T
ROIC 14.17%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩541,825
16.02%
(93.38%)
Hold 5|5|2|2|2
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
5,994
6,338
6,278
6,700
27.57%
39.47%
27.91%
23.39%
Revenue₩B
261.0
257.5
252.7
256.2
1.25%
(1.78%)
(1.14%)
(2.77%)
Peers (US$4.369B)
Cap (US$)
PE
4.421B
25.61x
1.179B
—
4.390B
32.67x
Capital
TTM
5Y
10Y
Leveragex
1.924
0.321
0.310
EBIT/Intx
0.403
0.228
0.226
Own earn%
(131.55)
(7.71)
(14.04)
Sh yield%
40.31
20.07
15.51
Owners
Insiders/Inst%
2.70
80.42
Short interest%
3.07
SBC / revenue%
1.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
15–20
$1 testx
0.7
Incr. ROIC%
6